title: Phosphatidylserine containing liposomes reduce immunogenicity of recombinant human factor VIII (rFVIII) in a murine model of hemophilia A.
abstract: Factor VIII (FVIII) is a multidomain protein that is deficient in hemophilia A, a clinically important bleeding disorder. Replacement therapy using recombinant human FVIII (rFVIII) is the main therapy. However, approximately 15-30% of patients develop inhibitory antibodies that neutralize rFVIII activity. Antibodies to epitopes in C2 domain, which is involved in FVIII binding to phospholipids, are highly prevalent. Here, we investigated the effect of phosphatidylserine (PS)-containing liposomes, which bind to C2 domain with high affinity and specificity, upon the immunogenicity of rFVIII. Circular dichroism studies showed that PS-containing liposomes interfered with aggregation of rFVIII. Immunogenicity of free- versus liposomal-rFVIII was evaluated in a murine model of hemophilia A. Animals treated with s.c. injections of liposomal-rFVIII had lower total- and inhibitory titers, compared to animals treated with rFVIII alone. Antigen processing by proteolytic enzymes was reduced in the presence of liposomes. Animals treated with s.c. injections of liposomal-rFVIII showed a significant increase in rFVIII plasma concentration compared to animals that received rFVIII alone. Based on these studies, we hypothesize that specific molecular interactions between PS-containing bilayers and rFVIII may provide a basis for designing lipidic complexes that improve the stability, reduce the immunogenicity of rFVIII formulations, and permit administration by s.c. route.
authors: Department of Pharmaceutical Sciences, University at Buffalo, State University of New York, Amherst, New York 14260, USA.
authors: Karthik
authors: K
authors: Ramani
authors: Razvan D
authors: RD
authors: Miclea
authors: Vivek S
authors: VS
authors: Purohit
authors: Donald E
authors: DE
authors: Mager
authors: Robert M
authors: RM
authors: Straubinger
authors: Sathy V
authors: SV
authors: Balu-Iyer
mesh_terms: D000818:Animals; D001682:Biological Availability; D005169:Factor VIII / Q000008:administration & dosage / Q000737:chemistry / Q000276:immunology* / Q000493:pharmacokinetics; D005260:Female; D006467:Hemophilia A / Q000188:drug therapy*; D008081:Liposomes; D008297:Male; D051379:Mice; D010718:Phosphatidylserines / Q000008:administration & dosage*; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000276:immunology
chemical_list: D008081:Liposomes; D010718:Phosphatidylserines; D011994:Recombinant Proteins; C078147:F8 protein, human; D005169:Factor VIII
references: Blood. 1989 Oct;74(5):1618-26
references: 2477082
references: Blood Rev. 1989 Sep;3(3):180-91
references: 2506958
references: J Biol Chem. 2005 May 6;280(18):17593-600
references: 15728582
references: J Immunol. 2005 Feb 1;174(3):1393-404
references: 15661897
references: J Biol Chem. 1959 Mar;234(3):466-8
references: 13641241
references: Thromb Haemost. 1999 Feb;81(2):240-4
references: 10063999
references: Blood. 1998 Nov 15;92(10):3701-9
references: 9808564
references: Immunopharmacology. 1989 Nov-Dec;18(3):167-76
references: 2532629
references: J Biol Chem. 1990 Jan 15;265(2):815-22
references: 2104832
references: Blood. 1990 May 15;75(10):1999-2004
references: 2110840
references: J Biol Chem. 1992 Aug 5;267(22):15861-8
references: 1639816
references: J Pharm Sci. 2005 Jun;94(6):1288-99
references: 15858858
references: J Pharm Sci. 2006 Feb;95(2):358-71
references: 16372314
references: Nature. 1999 Nov 25;402(6760):439-42
references: 10586887
references: Pharm Res. 2000 Mar;17(3):344-50
references: 10801224
references: Immunology. 2000 May;100(1):13-20
references: 10809954
references: Drugs. 2000 Sep;60(3):547-54
references: 11030466
references: Biochemistry. 2001 Jan 16;40(2):586-95
references: 11148054
references: Thromb Haemost. 2000 Nov;84(5):826-32
references: 11127864
references: Thromb Haemost. 2001 Jan;85(1):125-33
references: 11204564
references: Blood. 2002 Feb 15;99(4):1215-23
references: 11830468
references: Semin Thromb Hemost. 2002 Jun;28(3):309-22
references: 12098093
references: Nat Rev Drug Discov. 2002 Jun;1(6):457-62
references: 12119747
references: Clin Ther. 2002 Nov;24(11):1720-40; discussion 1719
references: 12501870
references: Vox Sang. 2002 Aug;83 Suppl 1:403-8
references: 12617176
references: Semin Thromb Hemost. 2003 Feb;29(1):61-8
references: 12640567
references: J Thromb Haemost. 2003 Feb;1(2):220-6
references: 12871492
references: Biol Chem. 2003 Jun;384(6):883-90
references: 12887055
references: J Thromb Haemost. 2003 Aug;1(8):1777-84
references: 12911593
references: Biochim Biophys Acta. 2003 Oct 31;1617(1-2):31-8
references: 14637017
references: Blood Coagul Fibrinolysis. 2004 Mar;15(2):109-24
references: 15090997
references: J Pharm Sci. 2004 Sep;93(9):2184-204
references: 15295780
references: J Pharm Sci. 2004 Oct;93(10):2549-57
references: 15349964
references: Thromb Haemost. 2004 Sep;92(3):522-8
references: 15351848
references: J Pharm Sci. 2004 Nov;93(11):2645-68
references: 15389672
references: Biochim Biophys Acta. 1981 Jan 8;640(1):66-81
references: 6163457
references: Scand J Haematol Suppl. 1984;41:13-24
references: 6440279
references: Crit Rev Ther Drug Carrier Syst. 1987;3(2):123-93
references: 3542245
references: Q J Med. 1987 Jun;63(242):473-91
references: 2889239
references: Immunopharmacology. 1992 May-Jun;23(3):205-13
references: 1500286
references: Thromb Res. 1992 Jul 1;67(1):57-71
references: 1440515
references: Pharm Res. 1993 May;10(5):649-59
references: 7686672
references: Biochim Biophys Acta. 1993 Jul 25;1150(1):9-16
references: 8334142
references: Biochemistry. 1993 Sep 21;32(37):9577-85
references: 8373765
references: FEBS Lett. 1993 Jun 21;324(3):325-30
references: 8405375
references: Thromb Haemost. 1993 Jul 1;70(1):63-7
references: 8236116
references: Thromb Haemost. 1995 Feb;73(2):247-51
references: 7792738
references: Nat Genet. 1995 May;10(1):119-21
references: 7647782
references: Blood. 1995 Sep 1;86(5):1811-9
references: 7544643
references: Thromb Haemost. 1997 Jul;78(1):647-51
references: 9198232
references: J Biol Chem. 1997 Jul 18;272(29):18007-14
references: 9218428
references: Biochim Biophys Acta. 1997 Sep 4;1328(2):261-72
references: 9315622
references: Pharm Res. 1997 Oct;14(10):1472-8
references: 9358564
references: J Pharm Sci. 1998 Sep;87(9):1069-76
references: 9724556